SBIR/STTR Research Award
Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection
Award amount
$249,563Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- Technology Holding, LLC
- Proposal award date
- 2021-02-10
- Contract end date
- 2021-09-09
- UEI
- U52NGYKN42H6
- Solicitation number
- 20.2
- Topic code
- DHA202-003
Research abstract
Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising drug class that could be applied to antibiotic resistant infections to harness a patients own immune system to effectively combat the invading threat. In this program we present an optimized workflow to yield high affinity monoclonal antibody candidates against surface antigens from common infectious disease which is increasingly antibiotic resistant.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- High Energy Density Synthetic Fuel
- Novel Method to Produce Renewable JP10
- HoodLab - A system for neighborhood scale environmental data visualization, crowdsourcing and data exploration tool using edge processing for real-time updates
- Honeycomb Hollow Carbon Fiber Composites
- Innovative Method for Development of Hemp based Fabric
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of Human Monoclonal Antibody Therapeutic Against Klebsiella pneumoniae Infection
- Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection
Research funding history
138 SBIR/STTR records share this UEI (1983–2025). Reported award amounts total $44,688,257. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Energy, National Science Foundation, National Aeronautics and Space Administration, Environmental Protection Agency, Department of Agriculture